| |
Males
|
Females
|
Persons
|
|---|
|
Cancer
|
O Asbest
b
|
ASR Asbest
|
ASR Sverdlovsk
|
SMR (95 % CI)
|
O Asbest
b
|
ASR Asbest
|
ASR Sverdlovsk
|
SMR (95 % CI)
|
O Asbest
b
|
ASR Asbest
|
ASR Sverdlovsk
|
SMR (95 % CI)
|
|---|
|
Respiratory
| | | | | | | | | | | | |
|
Larynx
|
48
|
15.6
|
12.0
|
1.29 (0.95–1.71)
|
3
|
0.7
|
0.4
|
1.40 (0.29–4.08)
|
51
|
6.1
|
4.7
|
1.30 (0.97–1.71)
|
|
Trachea, bronchus, lung
|
489
|
161.2
|
132.6
|
1.20 (1.10–1.31)
|
112
|
19.3
|
11.3
|
1.76 (1.45–2.12)
|
601
|
69.9
|
55.1
|
1.29 (1.18–1.39)c
|
|
Other respiratory
|
13
|
3.8
|
2.3
|
1.78 (0.95–3.05)
|
5
|
0.9
|
0.7
|
1.37 (0.44–3.20)
|
18
|
2.2
|
1.3
|
1.65 (0.98–2.61)
|
|
Digestive
| | | | | | | | | | | | |
|
Oesophagus
|
51
|
16.9
|
11.3
|
1.46 (1.09–1.92)
|
15
|
2.6
|
1.8
|
1.43 (0.80–2.35)
|
66
|
7.6
|
5.3
|
1.46 (1.13–1.85)
|
|
Stomach
|
188
|
61.9
|
55.1
|
1.12 (0.96–1.29)
|
165
|
30.1
|
23.2
|
1.28 (1.10–1.50)
|
353
|
41.4
|
34.6
|
1.19 (1.07–1.32)
|
|
Small intestine
|
4
|
1.3
|
1.3
|
1.02 (0.28–2.61)
|
6
|
1.1
|
0.7
|
1.49 (0.55–3.24)
|
10
|
1.2
|
0.9
|
1.26 (0.60–2.31)
|
|
Colon
|
86
|
28.7
|
23.6
|
1.24 (0.99–1.53)
|
145
|
25.9
|
18.1
|
1.42 (1.20–1.67)
|
231
|
26.7
|
19.7
|
1.35 (1.18–1.53)
|
|
Rectum
|
80
|
27.9
|
22.5
|
1.20 (0.95–1.49)
|
73
|
12.7
|
12.6
|
1.04 (0.81–1.31)
|
153
|
17.5
|
15.8
|
1.12 (0.95–1.31)
|
|
Other digestive
|
145
|
47.2
|
36.5
|
1.29 (1.09–1.52)
|
126
|
22.6
|
20.5
|
1.09 (0.91–1.30)
|
271
|
31.7
|
26.6
|
1.19 (1.05–1.34)
|
|
Hematopoietic
| | | | | | | | | | | | |
|
Leukaemia
|
33
|
11.4
|
9.1
|
1.18 (0.81–1.66)
|
37
|
7.1
|
5.1
|
1.37 (0.97–1.89)
|
70
|
8.2
|
6.5
|
1.28 (0.99–1.62)
|
|
Other hematopoietic
|
29
|
9.1
|
8.4
|
1.08 (0.72–1.55)
|
38
|
7.0
|
5.2
|
1.40 (0.99–1.93)
|
67
|
8.0
|
6.4
|
1.24 (0.96–1.58)
|
|
Male genital
| | | | | | | | | | | | |
|
Prostate
|
67
|
23.4
|
21.5
|
1.09 (0.85–1.39)
| | | | | | | | |
|
Other male genital
|
7
|
2.3
|
1.5
|
1.47 (0.59–3.03)
| | | | | | | | |
|
Breast
| | | | |
194
|
37.8
|
32.1
|
1.19 (1.03–1.37)
| | | | |
|
Female genital
| | | | | | | | | | | | |
|
Cervix
| | | | |
35
|
7.0
|
8.3
|
0.86 (0.60–1.20)
| | | | |
|
Uterus
| | | | |
51
|
9.7
|
9.0
|
1.05 (0.78–1.39)
| | | | |
|
Other female genital
| | | | |
65
|
12.5
|
14.5
|
0.86 (0.66–1.10)
| | | | |
|
Lip, oral cavity, pharynx
|
28
|
9.2
|
13.7
|
0.65 (0.43–0.94)
|
14
|
2.3
|
2.1
|
1.21 (0.66–2.03)
|
42
|
5.0
|
6.5
|
0.77 (0.56–1.04)
|
|
Urinary tract
|
116
|
38.8
|
29.4
|
1.31 (1.08–1.57)
|
40
|
7.1
|
6.8
|
1.05 (0.75–1.43)
|
156
|
18.2
|
14.7
|
1.24 (1.05–1.45)
|
|
Other/unspecified
|
118
|
37.7
|
35.1
|
1.07 (0.88–1.28)
|
127
|
23.4
|
20.0
|
1.20 (1.00–1.43)
|
245
|
29.0
|
25.6
|
1.14 (1.00–1.29)
|
-
aAge-standardized rates for ages 20+ calculated using European standard (5-year age groups 20–69, and 70+)
-
bNumber of cases observed in Asbest city
-
cMale and female SMRs statistically significantly different (p < 0.05) based on likelihood ratio test
